Emcure Pharmaceuticals Reports 24% Rise in Q4 Net Profit on International Growth
1 hour agoBusiness
31LENS
4 SourcesNew Delhi, India
TBNthebalanced.news

Emcure Pharmaceuticals Reports 24% Rise in Q4 Net Profit on International Growth

Emcure Pharmaceuticals reported a 24 percent rise in consolidated net profit to Rs 243.74 crore for the quarter ended March 2026, driven by a 25.7 percent increase in international sales to Rs 1,493 crore. Domestic sales grew 5.2 percent to Rs 977 crore, with some softness attributed to its Zuventus portfolio and team reorganisation. Consolidated revenue reached Rs 2,469.7 crore in Q4 and Rs 9,203.54 crore for FY26, with net profit at Rs 941.27 crore. CEO Satish Mehta highlighted strong international momentum and ongoing R&D focus.

Political Bias
0%100%0%
Sentiment
71%
AI analysis of 4 sources · Published under editorial oversight by The Balanced News
Analysed 5 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 4 sources
● Left 0%● Center 100%● Right 0%

The article group presents a primarily business-focused perspective without explicit political framing. Coverage centers on financial results, company statements, and market reactions, reflecting corporate and investor viewpoints. There is no evident political bias, as sources report factual earnings data and management comments without partisan interpretation or policy critique.

Sentiment — Positive (71/100)

The overall sentiment is mixed to positive, emphasizing strong profit growth and international business momentum. However, some articles note a stock price decline due to profit booking and mention softer domestic performance, introducing a cautious tone. The coverage balances financial achievements with market reactions, resulting in a measured and neutral tone.

How 4 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
businessstandardEmcure Pharmaceuticals Q4 results: Net profit rises 24 to 243.74 croreCenterPositive
businessstandardEmcure Pharmaceuticals consolidated net profit rises 28.81 in the March 2026 quarterCenterPositive
moneycontrolEmcure Pharma shares slide 6 post-Q4 results on profit booking- Moneycontrol.comCenterNeutral
news18Emcure Pharmaceuticals Q4 net profit rises 24 pc to Rs 243.74 crCenterPositive

Coverage timeline

news18 broke this story on 5 May, 10:08 am. Other outlets followed.

  1. 1
    news185 May, 10:08 am
    Emcure Pharmaceuticals Q4 net profit rises 24 pc to Rs 243.74 cr
  2. 2
    moneycontrol5 May, 10:13 am
    Emcure Pharma shares slide 6 post-Q4 results on profit booking- Moneycontrol.com
  3. 3
    businessstandard5 May, 10:19 am
    Emcure Pharmaceuticals consolidated net profit rises 28.81 in the March 2026 quarter
  4. 4
    businessstandard5 May, 10:30 am
    Emcure Pharmaceuticals Q4 results: Net profit rises 24 to 243.74 crore

Lens Score breakdown

31/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
Zuventus Healthcare LtdEmcure PharmaceuticalsEmcure Pharmaceuticals Ltd

Story context

Category
Business
Location
New Delhi, India
Sources analysed
4
Last analysed
5 May 2026
Key entities
Emcure PharmaceuticalsCroreIndian rupeeNet incomeChief executive officerDividendResearch and developmentShareholderUnited States dollarSubsidiaryBiosimilarStakeholder (corporate)